论文信息 - A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group. - 字舞流文

A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

M. Piccart | J. Wanders | J. Verweij | I. Judson | C. Sessa | P. D. De Mulder | J. Vermorken | U. Bruntsch | G. Catimel | M. Clavel